athenahealth, Humana, and Your Health Closing Critical Gaps at the Point of Care While Reducing Administrative Burden on Clinicians
BOSTON--(BUSINESS WIRE)--athenahealth, a leading provider of network-enabled software and services for healthcare practices nationwide, in collaboration with key partners Humana (NYSE: HUM) and Your Health, a South Carolina-based primary care practice, have received a 2025 Points of Light Award from KLAS. This recognition is for the case study, ' Closing Care Gaps & Reducing the Administrative Burden Through Improved Data Sharing.' This recognition highlights how integrating timely and relevant information directly into the clinical workflow can help improve health outcomes for patients.
"Facilitating collaboration between payer and provider organizations to improve care and eliminate administrative tasks is how we can deliver care experience that patients expect and deserve,' said Sam Lambson, VP of Product Management, Data and Ecosystem.
'At Your Health, our clinicians focus on delivering care that's preventative, personalized, and high-quality. This requires our staff to track patients and their health beyond the clinic and identify and address care gaps before they escalate to more serious or costly conditions,' said Will Stillinger, chief operating officer, Your Health. 'Humana and athenahealth have established an open and seamless information exchange that helps us deliver better care while eliminating administrative burden and costly interventions. We are excited by the opportunity for future care intervention pathways based on factors like Social Determinants of Health.'
To accomplish this real-time data exchange, Humana and athenahealth partnered to implement athenaPayer's Care and Diagnosis Gaps solutions to identify and surface care and diagnosis gaps among Humana's Medicare Advantage members. Utilizing athenahealth's cloud-based, single instance platform, Your Health clinicians can now see relevant patient information ahead of visits, address identified gaps during the visit, and document diagnoses and care plans directly within athenaOne. Leveraging Da Vinci APIs, athenahealth automatically sends validated data back to Humana to appropriately document and report on the quality of care they provide to members.
As the case study reports, athenahealth has uncovered an average of 4.8 additional care gaps and 4.7 additional diagnosis gaps per member among Humana's Medicare Advantage population, and Humana has been able to close 35% of its CMS Star gaps. Your Health clinicians now spend less time identifying care gaps with limited information, improving care while reducing documentation time.
'By investing in improving preventive care and management of chronic conditions, we're able to help our members stay healthier and out of the hospital. And that leads to lower costs for members themselves,' said Chris Walker, associate vice president of Enterprise Transformation and Interoperability, Humana. 'This partnership – and the positive results we've collectively achieved – is another example of how we are working together to improve patient care and deliver better health outcomes.'
athenahealth continues to expand its work with payer organizations, boosting information sharing across its network of more than 160,000 providers and facilitating new pathways to improve patient outcomes. To date, athenahealth has surfaced information on more than 25 million care and diagnosis gaps across commercial, Medicare, Medicaid, and ACA lines of business. The company has additional solutions that support provider and payer collaboration, including electronic prior authorization, transition of care, and referral management capabilities.
'We are working to create a thriving healthcare ecosystem that delivers accessible, high-quality, and sustainable care for all,' said Sam Lambson, vice president of Product Management, Data and Ecosystem Platform for athenahealth. 'Our work with Humana and Your Health is an example of exactly what that ecosystem can look like when practices are equipped with purpose-built, innovative solutions that ease clinician burden and enhance patient outcomes. Facilitating collaboration between payer and provider organizations to improve care and eliminate administrative tasks is how we can deliver care experience that patients expect and deserve.'
The KLAS Points of Light annual awards celebrate success stories achieved by payers, healthcare organizations, and healthcare IT companies who have partnered to reduce costs and inefficiencies and improve patient experience. The organizations are honored by the recognition and recently presented about their collaboration at the KLAS K2 Collaborative Summit, May 20-22 in Salt Lake City, UT.
To learn more about the challenges, outcomes, and key lessons from this collaboration, please visit: https://www.athenahealth.com/KLAS-POL-2025.
About athenahealth, Inc.
athenahealth strives to cure complexity and simplify the practice of healthcare. Our innovative technology includes electronic health records, revenue cycle management, and patient engagement solutions that help healthcare providers, administrators, and practices eliminate friction for patients while getting paid efficiently. athenahealth partners with practices with purpose-built software backed by expertise to produce the insights needed to drive better clinical and financial outcomes. We're inspired by our vision to create a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all. Learn more at athenahealth.com.
About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
About Your Health
Your Health is a leading healthcare organization and physician group committed to providing high-quality, patient-centered care across various specialties, including primary and specialty care for seniors in South Carolina, Georgia, and Florida. With 300 physicians, we deliver care in homes, local offices, facilities, and virtually, ensuring services are available wherever needed. Through continuous education and clinical excellence, Your Health aims to improve health outcomes and enhance community well-being. Our team collaborates closely with families and partners to provide coordinated, compassionate care that prioritizes patients. For more information, please visit www.yourhealth.org.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
5 Timely Ideas To Improve Medicare Advantage
WASHINGTON, DC - MARCH 14: Dr. Mehmet Oz, arrives for his confirmation hearing with the Senate ... More Finance Committee in the Dirksen Senate Office Building on March 14, 2025 in Washington, DC. Oz is U.S. President Donald Trump's nominee to be administrator of the Centers for Medicare and Medicaid Services. (Photo by) In April, Dr. Mehmet Oz became Administrator of the Centers for Medicare & Medicaid Services (CMS). While his appointment generated a buzz, it is the work ahead that truly matters, especially when it comes to Medicare Advantage (MA), the program that provides care to about 33 million people, or 54 percent of the Medicare population. Though MA is poised to provide the best outcomes for the most Americans, the program is also ripe for reform, and there are several critical areas Oz could focus on to drive meaningful improvement. Here are five: 1. Pilot Multiyear Enrollment in Plans. MA plans looking to make investments in prevention and effective treatment face a conundrum: people under our care drop out of our plans on an annual basis. One way to fix this is to move away from annual enrollment and create options for people to enroll in plans for several years at a time. Dr. Oz has called for 'shifting the paradigm for health care from a system that focuses on sick care to one that fosters prevention, wellness, and chronic disease management.' Multiyear enrollment would provide the necessary incentives to achieve this worthy goal because you can't really invest in improving health in 1-year increments. 2. Standardize Plan Benefits. Plans should be competing based on excellence and their proven abilities to drive outcomes, not edge benefits and giveaways like cash rebates. By adopting standardized plan benefits and requiring them to address genuine health needs, CMS could ensure that when consumers choose plans on the basis of plan quality and health outcomes—which should be the most important metric in their decision-making process. 3. Reform Broker Commissions. Lately, there's been a lot of talk about reforming the way MA brokers are compensated. Last year, CMS issued a rule capping broker compensation, but that rule was blocked by a judge before it took effect. And recently, the Department of Justice alleged in a lawsuit that insurers were paying kickbacks to brokers in return for steering beneficiaries toward their plans. Amid these developments, we too rarely discuss ways to encourage brokers to steer people toward higher-quality plans. It's time to align broker commissions with plan ratings. Under this approach, a broker who enrolls a client in a higher-rated plan would receive a larger commission than one who steers a client toward a lower-rated plan. CMS estimates that last year almost 38% of MA enrollment was in plans with fewer than four stars. We owe it to plan members to create a system that provides their brokers with every incentive to help them choose plans of the highest quality. 4. Reform the Broker Industry to Focus More on Clinical Support. While we'refocusing on brokers, let's also provide them with incentives to use their expertise more expansively to improve health. I've spoken to brokers who help clients find care and navigate medical bureaucracies, locate the best prices on medications, and even connect them with life-saving social services. Brokers earn renewal fees when their clients sign up annually for MA plans. Those renewal fees should be earned by annually providing clients with care navigation and other health services that drive positive clinical outcomes. Brokers who don't offer such services should receive reduced renewal fees—or maybe not continue to serve seniors at all. Either way, it's worth noting how many outstanding brokers already do this work and are among the most trusted members of their communities—exactly the kind of behaviors that should be rewarded. 5. Incentivize Integration Between Health Plans and Provider Organizations. There's a lot of friction in our healthcare system, especially between health plans and provider organizations. Plans allege providers drive up costs with unnecessary procedures, tests and prescription medications; providers say plans are inflexible and stand in the way of appropriate patient care. It's beyond time to change the dynamic between these two groups. Many have already discovered that the best way to do this is to enter into global capitation arrangements by which providers receive a fee to manage all of a plan member's healthcare expenses. The benefit of these arrangements is that they encourage each group to focus on what they do best: payers manage risk while providers make decisions about direct care. The best of these arrangements are true partnerships in which payers and providers transparently design products together that play to both groups' strengths with an orientation toward improving outcomes. Going forward, it would be in patients' interests for CMS to offer a standardized framework for payers and providers to collaborate in this way. The appointment of a new CMS Administrator presents a unique opportunity to enact substantial and lasting changes. That's certainly the case with Dr. Mehmet Oz. By focusing on these five key areas, he can help unleash the full potential of Medicare Advantage, benefiting older adults across the country.
Yahoo
6 hours ago
- Yahoo
Oscar Health (OSCR) Skyrockets 52% W/W. Time to Take Profits?
Oscar Health, Inc. (NYSE:OSCR) is one of the . Oscar Health jumped by 52 percent week-on-week, finishing at $21.22 versus the $13.95 on June 13, with analysts naming it a meme stock amid the lack of clear catalysts to boost buying appetite. Last week's shortened trading saw Oscar Health, Inc. (NYSE:OSCR) trade higher for four consecutive days, reflecting strong investor confidence amid macroeconomic uncertainties. Additionally, sentiment may have been supported by a new proposal for the Medicare Advantage, called 'Part E,' that would allow individuals and employers to enroll voluntarily. While this would heighten competition with private insurers, the voluntary enrollment could potentially delay or prevent Medicare's sooner-than-expected insolvency, and indirectly benefit Oscar Health, Inc. (NYSE:OSCR) and other private insurers. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 hours ago
- Yahoo
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
The average healthcare stock has a yield of just 1.7%. Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. 10 stocks we like better than Medtronic › The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better. For example, Medtronic (NYSE: MDT) has a 3.3% yield today, and Alexandria Real Estate Equities (NYSE: ARE) is offering a yield of 7.4%. Here's what you need to know about each of these high-yield healthcare stocks. Medtronic makes medical devices. It is one of the largest competitors in the space, making products across the cardiovascular, neuroscience, medical surgical, and diabetes categories. It has a leading position in each of the areas in which it operates, and it operates on a global scale. That said, the last few years haven't been the best ones for the company. Innovation, which is highly important in the healthcare space, can be lumpy. And given Medtronic's size, the business has become a little cumbersome. Growth has stalled out, and profitability has come under pressure. Investors have focused on the negatives pushing the shares lower and the dividend yield up toward the high end of Medtronic's historical yield range. If you are a dividend investor that thinks in decades and not days, however, this is likely to be an investment opportunity. The company's innovation pipeline is starting to turn into new-product introductions. As new products gain traction, financial performance is likely to improve. And management has been working to streamline the business with cost cuts and a move to refocus on its most profitable operations. To that end, the company is set to spin off its lower-margin diabetes division in 2026. The move is expected to be immediately accretive to earnings, and the dividend policy isn't expected to change. All in, Medtronic is doing what it needs to do to get back on the growth path. And that should support continued dividend increases; the medical device maker only has two years to go before it hits Dividend King status (50+ years of annual dividend increases). June could be an opportune time to buy the stock hand over fist. Alexandria is a real estate investment trust (REIT), which seems pretty far away from healthcare. Its primary focus is on office properties, which also seems a bit removed from healthcare. The key here is that the REIT owns biomedical research facilities, which combine research space and office space in one property. Both are important to each other since the research takes place in specialized space, while the analysis of that research takes place in a normal office environment. Alexandria is one of the largest pure play medical research REITs you can buy. Alexandria counts some of the largest and most important medical research groups as tenants, from both the private side of the equation and the government side. However, like any landlord, the REIT's revenues will be impacted by the occupancy levels of its properties. And those rise and fall over time. Right now, occupancy is relatively weak, dropping to 91.7% at the end of the first quarter of 2025 from 94.6% at the end of 2024. Swings like this happen from time to time, but Wall Street is treating Alexandria as if its dividend is at a material risk of being cut. Only the funds from operations (FFO) payout ratio in the first quarter was a fairly strong 57%. There's room for adversity before a dividend cut would be in order. To be fair, office properties, and particularly highly specialized office properties, tend to have higher operating costs than other real estate assets. But it seems highly likely that Alexandria will manage its way through this weak patch and continue to extend its 15-year streak of annual dividend increases. For income lovers, this healthcare REIT is worth a deep dive in June. The average healthcare stock has an uninspiring dividend yield. But the average is made up of many different companies, some of which actually have very attractive dividend yields. That list includes industry-leading companies like Medtronic and Alexandria Real Estate. You might just want to pick up shares in one, or both, of these high yielders before June is over after you get to know them a little better. Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
